Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAB39A | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | DOPEY1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | RPS6KA6 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | NUDT3 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | SIRT2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | CHRNB2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |